•  
  •  
  •  
  •  

2026-08-12 00:50:34

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  Pharmaceuticals

Research

  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Innova Captab Limited reported strong results for Q1 FY27, with Revenue from Operations at ₹ 470.9 crores and EBITDA at ₹ 75.1 crores
  • Viyash Scientific Delivers Strong Q1 FY27 Performance: PAT Surges 114.9% to ₹793 Million
  • Varenyam Biolifesciences to upgrade its upcoming Savli facility to offer biologics and biosimilar CDMO services for US, EU and SRA RoW markets
  • Fermenta Q1FY27 Consolidated Revenue INR 126.2 crore; flat QoQ and down 13% YoY
  • Zydus Lifesciences Reports Q1 FY27 Results: Operational Revenue Up 22% to ₹80,170 Million
  • AstraZeneca Pharma India Starts FY2026-27 with 30% Operational Revenue Growth Driven by Core Therapies
  • Jubilant Pharmova Reports 17% YoY Revenue Growth to ₹2,229 Crore in Q1 FY27; CDMO Sterile Injectables Surges 34%
  • Wockhardt Antibiotic Academy, an initiative for Patient - Centric Scientific Dialogue to Tackle Multidrug Resistance
  • Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
  • IOL Chemicals and Pharmaceuticals Delivers Strong Q1 FY27 Results with 89.9% YoY PAT Surge to ₹64.5 Crore
  • Zydus launches REVAHALE™, India's first once-daily nebulised LAMA for COPD
  • Lyka Labs Reports Q1 FY27 Financial Results; Consolidated Net Profit Surges 105.4% YoY
  • Gland Pharma Announces Strategic CDMO Partnership with a Global Pharmaceutical Company
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • GPCB Revokes Closure Notice for Aarti Drugs' Sayakha Plant; Operations Resume Following EDC Payment
  • Zydus Lifesciences Ltd receives EIR from the USFDA for its injectable facility with VAI classification
  • Divi's Laboratories Reports Strong Q1 FY27 Results: Consolidated PAT Soars 65% YoY to ₹902 Crore
  • Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-Term Strategic Growth
  • Glenmark Pharmaceuticals Announces Q1 FY27 Results
  • Lupin Announces the Approval of Diazepam Injection, USP in the United States
  • Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
  • Concord Biotech Limited Reports Q1 FY27 Results: Revenue Rises 26.2% YoY to ₹25,748.90 Lakhs
  • CORONA Remedies Reports Strong Q1 FY27 Performance: PAT Up 30.1% YoY to ₹60.1 Crore

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025